Literature DB >> 33634030

Antitumor Effect and Immune Response of Nanosecond Pulsed Electric Fields in Pancreatic Cancer.

Jing Zhao1,2, Shuochun Chen1, Lu Zhu1, Liang Zhang2,3, Jingqi Liu1, Danxia Xu1, Guo Tian1, Tian'an Jiang1,2.   

Abstract

Nanosecond pulsed electric fields (nsPEFs) have emerged as a novel and effective strategy for the non-surgical and minimally invasive removal of tumors. However, the effects of nsPEFs treatment on the tumor immune microenvironment remain unknown. In this study, the changes in the morphology and function of pancreatic cancer cells after nsPEFs were assessed and the modifications in the immune profile in pancreatic cancer models were investigated. To this end, electrodes were inserted with different parameters applied to ablate the targeted tumor tissues. Tumor development was found to be inhibited, with decreased volumes post-nsPEFs treatment compared with control tumors (P < 0.05). Hematoxylin and eosin staining showed morphological changes in pancreatic cancer cells, Ki-67 staining confirmed the effects of nsPEFs on tumor growth, and caspase-3 staining indicated that nsPEFs caused apoptosis in the early stages after treatment. Three days after nsPEFs, positron emission tomography demonstrated little residual metabolic activity compared with the control group. Gene expression profiling identified significant changes in immune-related pathways. After treatment with nsPEFs, CD8+ T lymphocytes increased. We showed that nsPEFs led to a significant decrease in immune suppressive cells, including myeloid derived suppressor cells, T regulatory cells, and tumor-associated macrophages. In addition, the levels of TNF-α and IL-1β increased (P < 0.05), while the level of IL-6 was decreased (P < 0.05). NsPEFs alleviated the immunosuppressive components in pancreatic cancer stroma, including hyaluronic acid and fibroblast activation protein-α. Our data demonstrate that tumor growth can be effectively inhibited by nsPEFs in vivo. NsPEFs significantly altered the infiltration of immune cells and triggered immune response.
Copyright © 2021 Zhao, Chen, Zhu, Zhang, Liu, Xu, Tian and Jiang.

Entities:  

Keywords:  ablation; immune response; nanosecond pulsed electric fields; pancreatic cancer; tumor microenvironment

Year:  2021        PMID: 33634030      PMCID: PMC7900424          DOI: 10.3389/fonc.2020.621092

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  36 in total

1.  Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42.

Authors:  Gina L Razidlo; Kevin M Burton; Mark A McNiven
Journal:  J Biol Chem       Date:  2018-05-31       Impact factor: 5.157

2.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.

Authors:  Berna C Özdemir; Tsvetelina Pentcheva-Hoang; Julienne L Carstens; Xiaofeng Zheng; Chia-Chin Wu; Tyler R Simpson; Hanane Laklai; Hikaru Sugimoto; Christoph Kahlert; Sergey V Novitskiy; Ana De Jesus-Acosta; Padmanee Sharma; Pedram Heidari; Umar Mahmood; Lynda Chin; Harold L Moses; Valerie M Weaver; Anirban Maitra; James P Allison; Valerie S LeBleu; Raghu Kalluri
Journal:  Cancer Cell       Date:  2014-05-22       Impact factor: 31.743

Review 3.  IL-6 roles - Molecular pathway and clinical implication in pancreatic cancer - A systemic review.

Authors:  Vlad-Vasile Pop; Andrada Seicean; Iulia Lupan; Gabriel Samasca; Claudia-Cristina Burz
Journal:  Immunol Lett       Date:  2016-11-19       Impact factor: 3.685

4.  IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.

Authors:  Thomas A Mace; Reena Shakya; Jason R Pitarresi; Benjamin Swanson; Christopher W McQuinn; Shannon Loftus; Emily Nordquist; Zobeida Cruz-Monserrate; Lianbo Yu; Gregory Young; Xiaoling Zhong; Teresa A Zimmers; Michael C Ostrowski; Thomas Ludwig; Mark Bloomston; Tanios Bekaii-Saab; Gregory B Lesinski
Journal:  Gut       Date:  2016-10-21       Impact factor: 23.059

5.  Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.

Authors:  W-Q Wang; L Liu; H-X Xu; C-T Wu; J-F Xiang; J Xu; C Liu; J Long; Q-X Ni; X-J Yu
Journal:  Br J Surg       Date:  2016-06-03       Impact factor: 6.939

Review 6.  The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer.

Authors:  Qiqing Sun; Bo Zhang; Qiangsheng Hu; Yi Qin; Wenyan Xu; Wensheng Liu; Xianjun Yu; Jin Xu
Journal:  Theranostics       Date:  2018-10-06       Impact factor: 11.556

7.  Nanosecond pulsed electric field inhibits malignant melanoma growth by inducing the change of systemic immunity.

Authors:  X Zhang; Y Zhang; J Chen; Y Wu; J Zhang; J Wang
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2019-07-01

Review 8.  Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer.

Authors:  Stefano Lafranceschina; Oronzo Brunetti; Antonella Delvecchio; Maria Conticchio; Michele Ammendola; Giuseppe Currò; Tullio Piardi; Nicola de'Angelis; Nicola Silvestris; Riccardo Memeo
Journal:  Cancers (Basel)       Date:  2019-11-03       Impact factor: 6.639

Review 9.  Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer.

Authors:  Steffi J Rombouts; Marieke S Walma; Jantien A Vogel; Lennart B van Rijssen; Johanna W Wilmink; Nadia Haj Mohammad; Hjalmar C van Santvoort; I Quintus Molenaar; Marc G Besselink
Journal:  Ann Surg Oncol       Date:  2016-07-01       Impact factor: 5.344

10.  Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer.

Authors:  Lanyun Feng; Qi Qi; Peng Wang; Hao Chen; Zhen Chen; Zhiqiang Meng; Luming Liu
Journal:  J Int Med Res       Date:  2018-10-10       Impact factor: 1.671

View more
  7 in total

1.  Use of nanosecond pulsed electric fields in brain tumors.

Authors:  Saleha Azeem; Mohsin Rashid; Zaid Aljuboori
Journal:  Surg Neurol Int       Date:  2022-07-01

Review 2.  Electroporation and Immunotherapy-Unleashing the Abscopal Effect.

Authors:  Tobias Freyberg Justesen; Adile Orhan; Hans Raskov; Christian Nolsoe; Ismail Gögenur
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

Review 3.  Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer.

Authors:  Khan Mohammad Imran; Margaret A Nagai-Singer; Rebecca M Brock; Nastaran Alinezhadbalalami; Rafael V Davalos; Irving Coy Allen
Journal:  Front Oncol       Date:  2022-03-18       Impact factor: 5.738

Review 4.  The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer.

Authors:  Argyrios Gyftopoulos; Ioannis A Ziogas; Andrew S Barbas; Dimitrios Moris
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

5.  The Safety and Efficacy of Nanosecond Pulsed Electric Field in Patients With Hepatocellular Carcinoma: A Prospective Phase 1 Clinical Study Protocol.

Authors:  Min Xu; Danxia Xu; Gang Dong; Zhigang Ren; Wu Zhang; Tuerganaili Aji; Qiyu Zhao; Xinhua Chen; Tian'an Jiang
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

Review 6.  Effect of pulsed field ablation on solid tumor cells and microenvironment.

Authors:  Yujue Wang; Tian'an Jiang; Liting Xie; Huiyang Wang; Jing Zhao; Lei Xu; Chengyu Fang
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

7.  Liquid Biopsy and the Translational Bridge from the TIME to the Clinic.

Authors:  Paul Walker
Journal:  Cells       Date:  2022-10-03       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.